Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial

doi:10.3748/wjg.v25.i40.6158

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10318)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

615

WORD

439

HTML

4005

Figures (1-5)

430

Tables (1-2)

236

Sum=5725

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

742

Download

1018

Sum=1760

Publishing Process of This Article

Item

Count

Browse

1057

Download

1776

Sum=2833

Oct 28, 2019 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Clinical Trial

World J Gastroenterol. Oct 28, 2019; 25(40): 6158-6171
Published online Oct 28, 2019. doi: 10.3748/wjg.v25.i40.6158

Full Size Figure Download Figure

Figure 2 Flow chart of inclusion and follow-up of patients with inflammatory bowel disease. OD: On demand; 3M: Third month.

Citation: Ankersen DV, Weimers P, Marker D, Bennedsen M, Saboori S, Paridaens K, Burisch J, Munkholm P. Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial. World J Gastroenterol 2019; 25(40): 6158-6171
URL: https://www.wjgnet.com/1007-9327/full/v25/i40/6158.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i40.6158